Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2013

May 8, 2013

284_dirs_2013-05-08_c6a6eecf-2b58-4feb-bf86-f6d48e4d53c1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2013-05-06

Reporting Person: DeLuca Richard R. (EVP&Pres, Merck Animal Health)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-05-06 Stock Option (right to buy) $44.9800 A 70853.0000 Acquired 2023-05-05 Common Stock (70853.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 419.0660 Indirect

Footnotes

F1: Includes shares acquired and dividends through April 5, 2013 in the Merck U.S. Savings Plan, a 401(k) plan.

F2: The option vests in three equal annual installments beginning May 6, 2014.